Nicox S.A. Reports Net Revenue Results for the Fourth Quarter and Full Year of 2022
January 18, 2023 at 01:30 am EST
Nicox S.A. reported net revenue results for the fourth quarter and full year of 2022. Net revenue for the fourth quarter of 2022 was 1.0 million (consisting entirely of net royalty payments). This compares to net revenue for the fourth quarter of 2021 of 3.5 million (0.5 million of net royalty payments and a 3.0 million non-cash accounting adjustment initially recorded as deferred income following a licensing payment received from Ocumension Therapeutics in March 2020).
The net revenue for the full year 2022 was 3.3 million (consisting entirely of net royalty payments) compared to a net revenue for the full year 2021 of 7.2 million (2.4 million in net royalties, 4.8 million in license payments).